 heterogeneity human chorionic gonadotropin hCG III occurrence biological immunological activities nicked hCG Nicks peptide linkages hCG beta-subunit residues residues occurrence biological immunological activities nicked hCG sequence analysis standard hCG half beta half beta Treatment human leukocyte elastase extent nicking standard hCG incubation standard human leukocyte elastase extent nicked hCG extent receptor-binding ability ability progesterone production rat corpus luteal cells vitro microgram/microgram hCG regression analysis linear relationship extent nicking receptor binding values correlation extent nicking steroidogenic activity vitro correlation intercepts regression lines nicks receptor binding steroidogenic activity hCG individual hCG preparations pregnancy urine urine patients hydatidiform mole urine women choriocarcinoma order individual hCG preparations intact correlation percent intact ability individual samples hCG CG/LH receptor close correlation percent intact steroidogenic activity vitro correlation effects receptor binding steroidogenic activities multiple factors influence receptor binding steroidogenic activity bound hCG recognition nicked hCG molecules different hCG immunoassays Hybritech Tandem total hCG nicked intact hCG molecules regression analysis immunoactivity percent intact hCG contrast immunometric assay hCG dimer-specific monoclonal antibody anti-beta-peroxidase intact component hCG regression analysis immunoreactivity percent intact hCG correlation assays percentage intact hCG extent ABSTRACT TRUNCATED AT WORDS